An interdisciplinary team of UCLA scientists has found that small cell neuroendocrine cancers from a range of tissues have a common molecular signature and share drug sensitivities with blood cancers. The discoveries could improve the diagnoses of these aggressive cancers and lead to the development of new treatments that build upon the lessons learned from successful blood cancer therapies.
source https://www.lifetechnology.com/blogs/life-technology-news-blog/similarities-of-small-cell-cancers-to-blood-cancers-could-lead-to-better-treatments